Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IFrancesco Paneni, Francesco Cosentino|European Heart Journal|2013Cited by 1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesNikolaus Marx, Konstantinos C. Koskinas, Héctor Bueno et al.|European Heart Journal|2023Cited by 1.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of CardiologyPetar Seferović, John J.V. McMurray, Mark C. Petrie et al.|European Journal of Heart Failure|2018Cited by 716
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of HypertensionStefan D. Anker, Giuseppe Rosano, Muhammad Usman et al.|European Journal of Heart Failure|2023Cited by 187
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemiaRoberto Ferrari, Alberico L. Catapano, Carlos Aguíar et al.|European Heart Journal Supplements|2016Cited by 101